Cost-effectiveness of Short-Course Zidovudine to Prevent Perinatal HIV Type 1 Infection in a Sub-Saharan African Developing Country Setting

JAMA

Volumn 276, Issue 2, 1996, Pages 139-145

  Mansergh, Gordon ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ADULT; AFRICA; ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEWBORN; PERINATAL INFECTION; PRIORITY JOURNAL;

EID: 0029683590     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.2.139     Document Type: Article

References (29)

1. International Program Center, Population Division, US Bureau of the Census. Recent HIV Seroprevalence Level by Country: December 1994. Washington, DC: US Bureau of the Census; 1994: 21-51. Research Note No. 15.
2. International Program Center, Population Division, US Bureau of the Census. HIV/AIDS in Africa. Washington, DC: US Bureau of the Census; December 1995. Research Note No. 20.
3. Mofenson LM. Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis. 1994;5:252-2G5.
4. Hanson K. AIDS: What does economics have to offer? Health Policy Plann. 1992;7:315-328.
5. Gillespie S. Potential impact of AIDS on farming systems: a case study of Rwanda. Land Use Policy. 1989;6:301-312.
6. Norse D. Socioeconomic impact of AIDS on food production in East Africa. In: Program and abstracts of the Seventh International Conference on AIDS; June 16-21,1991; Florence, Italy. Abstract TU.D.57.
7. Over M, Bertozzi S, Chin J, et al. The direct and indirect cost of HIV infection in developing countries: the cases of Zaire and Tanzania. In: Fleming AF, Carballo M, FitzSimons DW, et al, eds. Global Impact of AIDS. New York, NY: Alan R Liss Inc; 1988:123-135.
8. Scitovsky A, Over M. AIDS: costs of care in the developed and developing world. AIDS. 1988;2:S71-S78.
9. Connor EM, Sperling RS, Gelber R, et al, for the Pédiatrie AIDS Clinical Trials Group Protocol 076 Study Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994; 331:1173-1180.
10. Cohen J. Bringing AZT to poor countries. Sci-ence. 1995;269:624-626.
11. Gorsky RD, Farnham PG, Straus WL, et al. Preventing perinatal HIV: costs and effectiveness of a recommended intervention. Public Health Rep. 1996;111:335-341.
12. Over M, Bertozzi S, Chin J. Guidelines for rapid estimation of the direct and indirect costs of HIV infection in a developing country. Health Policy. 1989;11:169-186.
13. UNICEF. The State of ihe World's Children, 1995. New York, NY: Oxford University Press; 1995.
14. World Bank. World Development Report 1994. New York, NY: Oxford University Press; 1994.
15. Adjorlolo-Johnson G, De Cock KM, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HI V-2 in Abidjan, Ivory Coast. JAMA. 1994;272:462-466.
16. Ekpini E, Wiktor SZ, Sibailly T, et al. Late postnatal mother-to-child HIV transmission in Abidjan, CI. In: Program and abstracts of the 10th International Conference on AIDS; August 7-12,1994; Yokohama, Japan. Abstract 218C.
17. Dunn DT, Newell ML, Ades AE, et al. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992;340:585-588.
18. Datta P, Embree J, Kreiss JK, et al. Motherto-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis. 1994;170:1134-1140.
19. World Health Organization. Global Programme on AIDS recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec. 1992;67:145-152.
20. Sato PA, Maskill WJ, Tamashiro H, et al. Strategies for lab HIV testing: an examination of alternative approaches not requiring Western blot. Bull World Health Organ. 1994;72:129-134.
21. Viravaidya M, Obremskey SA, Myers C. The économie impact of AIDS on Thailand. In: Bloom DE, Lyons JV, eds. Economic Implications of AIDS in Asia. New Dehli, India: United Nations Development Programme; 1993:7-34.
22. World Bank. Tanzania AIDS Assessment and Planning Study. Washington, DC: World Bank; 1992.
23. Parrott RH. Childhood human immunodeficiency virus infection: the spectrum of costs. J Acquir Immune Defic Syndr. 1991;4:122-129.
24. Cameron C, Tarantola D. The costs of AIDS care in the world, 1990. In: Program and abstracts of the Eighth International Conference on AIDS; July 19-24,1992. Amsterdam, the Netherlands. Abstract WeC 1038.
25. Aisu T, Raviglione MC, van Praag E, et al. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counseling and testing centre. AIDS. 1995;9:267-273.
26. Centers for Disease Control and Prevention. Recommendations of the US Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus. MMWR Morb Mortal Wkly Rep. 1994;43:1-20.
27. Centers for Disease Control and Prevention. US Public Health Service recommendations for human immunodeficiency virus counseling and testing for pregnant women. MMWR Morb Mortal Wkly Rep. 1995;44:1-15.
28. Heymann SJ. Modeling the impact of breastfeeding by HIV-infected women on child survival. Am J Public Health. 1990;80:1305-1309.
29. Hu DJ, Heyward WL, Byers RH, et al. HIV infection and breast-feeding: policy implications through a decision analysis model. AIDS. 1992;6:1505-1513.